Work

Stat Bite: Improvements in 5-year Relative Survival for Regional and Distant Stage Melanoma of the Skin

Year: 2024

Type: article

Abstract: Trends in 5-year relative survival rates for melanoma of the skin are shown by stage at diagnosis for both sexes, all races and ethnicities, and all ages from 2004 to 2016. Before 2008, only 17% of patients diagnosed with distant-stage melanoma survived five years post-diagnosis. Since then, this figure has more than doubled, with 37% of patients diagnosed in 2014 and later surviving at least five years. Trends also show 5-year survival starting to slightly decline for patients diagnosed after 2014. Source: SEER*Explorer, seer.cancer.gov/explorer. Note: We only show 5-year survival trends for patients diagnosed in 2016 because we have follow-up information through 2021. Emily Tonorezos (Conceptualization, Visualization, Writing—original draft, Writing—review & editing), Mark Sellers (Formal Analysis, Methodology, Validation, Visualization, Writing—review & editing), and Angela B. Mariotto (Conceptualization, Data curation, Formal Analysis, Methodology, Resources, Software, Supervision, Visualization, Writing—original draft, Writing—review & editing). No funding was used for this Stat Bite. The authors have no conflicts of interest to disclose.

Source: JNCI Journal of the National Cancer Institute

DOI: 10.1093/jnci/djae266

Authors: Emily S Tonorezos, Mark E Sellers, Angela B Mariotto

Institutions: National Institutes of Health, National Cancer Institute

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $5,708